JenKem Technology USA to exhibit at CPhI Worldwide

Visit JenKem’s stand 102B76 at CPhI Worldwide in Frankfurt, Germany, Oct. 24th- 26th, 2017.

JenKem at CPhI Frankfurt

 

 

 

JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEGs) derivatives and PEG raw materials, related custom PEG and co-polymer synthesis, and PEGylation services.

JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through GMP commercial scale.

Activated PEGs are especially useful in drug delivery and targeted diagnostics, as cross-linking agents or spacers between two chemical entities, whereas mono-functional PEGs prevent bridging reactions which can affect the PEGylation of certain compounds. Activated PEG derivatives with different terminal functional groups are widely used in the PEGylation of peptides, proteins, antibodies, small molecules, like folate, mannose, pro-drugs or oligonucleotides, cells, nanoparticles and virus particles, or surfaces. Multi-arm PEG derivatives are largely employed in the formation of hydrogels. Visit our stand or contact us to learn more.

Comments are closed.